DEA Attorney: Cannabis to be Rescheduled on August 1st
[Update, August 11, 2016: Unfortunately the DEA has decided not to reschedule cannabis, but instead has opened the door for more research. We apologize for misreporting this story.]
According to the Santa Monica Observer, on August 1st the Drug Enforcement Administration (DEA) will reschedule cannabis from a schedule 1 controlled substance, to a schedule 2 controlled substance, allowing it to be used and researched for medical purposes.
According to the Observer, a DEA attorney who wishes to remain anonymous made it clear that the agency, on August 1st, plans to remove cannabis as a schedule 1 drug – which indicates that it has no known medical value – and place it as a schedule 2 drug, allowing it to be used for medical purposes (other schedule 2 drugs include cocaine and Oxycontin).
“Whatever the law may be in California, Arizona or Utah or any other State, because of Federal preemption this will have the effect of making THC products legal with a prescription, in all 50 states,” the attorney told the Observer.
According to the attorney, the change has a lot to due with the fact that cannabis prohibition has become a “big drain” on resources, noting that a majority of Americans now support legalizing cannabis for all uses, not just medical.
In April, the DEA announced that it’s considering rescheduling cannabis, with a potential for it to be done before the end of summer.